Home/Pipeline/Adellgene Rare Disease Menu

Adellgene Rare Disease Menu

Triplet Repeat Disorders (e.g., Huntington's, Fragile X)

Commercial (iterative development)Active

Key Facts

Indication
Triplet Repeat Disorders (e.g., Huntington's, Fragile X)
Phase
Commercial (iterative development)
Status
Active
Company

About Blackhills Diagnostic Resources (BDR)

BDR is a privately held, revenue-generating diagnostics company with a fully integrated model from R&D to post-sale service. Its core expertise lies in molecular diagnostics, particularly in HLA genotyping for transplant compatibility and genetic testing for rare diseases like Huntington's. The company is ISO 13485:2016 and CE IVDR certified, positioning it as a specialized, compliant player in the European IVD market. Its strategy combines proprietary assay development with bioinformatics software to serve clinical laboratories.

View full company profile